<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7449939/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Comparison of antibiotic stewardship programme (ASP) interventions and outcomes pre-coronavirus disease 2019 (pre-COVID-19) (1 February–30 April 2019) and during the acceleration phase of the COVID-19 pandemic (1 February–30 April 2020)</p>
 </caption>
 <thead>
  <tr>
   <th valign="top" colspan="1" rowspan="1" id="0-0-.">Types of interventions</th>
   <th colspan="3" align="left" valign="top" rowspan="1" id="0-1-c">
    <span class="sc">p</span>re-COVID-19 
    <a rid="tb1fn1" ref-type="table-fn">a</a>, 
    <i>n</i> (%) 
    <i>n</i>=560 
   </th>
   <th colspan="2" align="left" valign="top" rowspan="1" id="0-4-b">COVID-19 
    <a rid="tb1fn2" ref-type="table-fn">b</a>, 
    <i>n</i> (%) 
    <i>n</i>=578 
   </th>
   <th valign="top" colspan="1" rowspan="1" id="0-6-.">
    <i>P-</i>value 
   </th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td valign="top">ASP acceptance</td>
   <td colspan="3" align="left" valign="top">470 (83.9)</td>
   <td colspan="2" align="left" valign="top">488 (84.4)</td>
   <td valign="top">0.89</td>
  </tr>
  <tr>
   <td valign="top">Type of ASP interventions</td>
   <td colspan="6" align="left" valign="top"/>
  </tr>
  <tr>
   <td valign="top">Broaden empirical coverage</td>
   <td colspan="3" align="left" valign="top">6 (1.1)</td>
   <td colspan="2" align="left" valign="top">9 (1.6)</td>
   <td valign="top">0.87</td>
  </tr>
  <tr>
   <td valign="top">Narrow empirical coverage</td>
   <td colspan="3" align="left" valign="top">102 (18.2)</td>
   <td colspan="2" align="left" valign="top">102 (17.6)</td>
   <td valign="top">1.00</td>
  </tr>
  <tr>
   <td valign="top">Revision of antibiotics based on culture data</td>
   <td colspan="3" align="left" valign="top">89 (15.9)</td>
   <td colspan="2" align="left" valign="top">73 (12.6)</td>
   <td valign="top">1.00</td>
  </tr>
  <tr>
   <td valign="top">Discontinuation of antibiotics</td>
   <td colspan="3" align="left" valign="top">217 (38.8)</td>
   <td colspan="2" align="left" valign="top">181 (31.3)</td>
   <td valign="top">0.69</td>
  </tr>
  <tr>
   <td valign="top">IV to PO switch</td>
   <td colspan="3" align="left" valign="top">64 (11.4)</td>
   <td colspan="2" align="left" valign="top">79 (13.7)</td>
   <td valign="top">0.49</td>
  </tr>
  <tr>
   <td valign="top">Optimization of antibiotic doses</td>
   <td colspan="3" align="left" valign="top">24 (4.3)</td>
   <td colspan="2" align="left" valign="top">71 (12.3)</td>
   <td valign="top">0.56</td>
  </tr>
  <tr>
   <td valign="top">Trigger ID consult or ID review</td>
   <td colspan="3" align="left" valign="top">35 (6.3)</td>
   <td colspan="2" align="left" valign="top">30 (5.2)</td>
   <td valign="top">0.11</td>
  </tr>
  <tr>
   <td valign="top">Additional recommendations 
    <a rid="tb1fn3" ref-type="table-fn">c</a>
   </td>
   <td colspan="3" align="left" valign="top">23 (4.1)</td>
   <td colspan="2" align="left" valign="top">33 (5.7)</td>
   <td valign="top">0.70</td>
  </tr>
  <tr>
   <td valign="top">Impact of ASP interventions</td>
   <td align="left" valign="top">Accepted</td>
   <td align="left" valign="top">Rejected</td>
   <td align="left" valign="top">
    <i>P</i>-value 
   </td>
   <td align="left" valign="top">Accepted</td>
   <td align="left" valign="top">Rejected</td>
   <td valign="top">
    <i>P</i>-value 
   </td>
  </tr>
  <tr>
   <td valign="top">Median duration of antibiotic therapy (IQR), days</td>
   <td align="left" valign="top">3 (2–5)</td>
   <td align="left" valign="top">6 (4–10)</td>
   <td align="left" valign="top">&lt;0.05 
    <a rid="tb1fn4" ref-type="table-fn">d</a>
   </td>
   <td align="left" valign="top">4 (2-4)</td>
   <td align="left" valign="top">8 (3.0 – 9)</td>
   <td valign="top">&lt;0.05 
    <a rid="tb1fn4" ref-type="table-fn">d</a>
   </td>
  </tr>
  <tr>
   <td valign="top">Median LOS after ASP intervention (IQR), days</td>
   <td align="left" valign="top">6 (2–15)</td>
   <td align="left" valign="top">7 (4–11)</td>
   <td align="left" valign="top">0.53</td>
   <td align="left" valign="top">7 (4–16)</td>
   <td align="left" valign="top">12 (7–28)</td>
   <td valign="top">&lt;0.01 
    <a rid="tb1fn4" ref-type="table-fn">d</a>
   </td>
  </tr>
 </tbody>
 <tfoot>
  <p class="fn" charset="fn">
   <p>IV, intravenous; PO, per oral; IQR, interquartile range; LOS, length of stay; ID, infectious diseases.</p>
  </p>
  <p class="fn" charset="fn" id="tb1fn1">
   <p class="label">a</p>
   <p id="notep0002">pre-COVID-19: this refers to the period between 1 February and 30 April 2019.</p>
  </p>
  <p class="fn" charset="fn" id="tb1fn2">
   <p class="label">b</p>
   <p id="notep0003">COVID-19: this refers to the period between 1 February and 30 April 2020.</p>
  </p>
  <p class="fn" charset="fn" id="tb1fn3">
   <p class="label">c</p>
   <p id="notep0004">Recommendations for diagnostic investigations and/or infection control precautions were made to guide management of the ID issues.</p>
  </p>
  <p class="fn" charset="fn" id="tb1fn4">
   <p class="label">d</p>
   <p id="notep0005">
    <i>P</i>&lt;0.05 was taken to indicate statistical significance. 
   </p>
  </p>
 </tfoot>
</table>
